Prolonged Exposure to Caplacizumab as Rescue Therapy in Refractory Immune Thrombotic Thrombocytopenic Purpura

We describe a case of refractory thrombotic thrombocytopenic purpura (7 lines of therapy) in which caplacizumab was used over a 6-month period as rescue therapy. Caplacizumab maintained the patient in clinical remission until successful immunosuppression was achieved resulting in normal ADAMTS13 lev...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodgers, George M, Berndt, Misa, Fonteno, Megan, Gilreath, Jeffrey A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987240/
https://www.ncbi.nlm.nih.gov/pubmed/36891167
http://dx.doi.org/10.2147/JBM.S395248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987240/
https://www.ncbi.nlm.nih.gov/pubmed/36891167
http://dx.doi.org/10.2147/JBM.S395248

Ejemplares similares